nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivastigmine—CYP2D6—Vinorelbine—ovarian cancer	0.0775	0.255	CbGbCtD
Rivastigmine—CYP3A4—Topotecan—ovarian cancer	0.07	0.23	CbGbCtD
Rivastigmine—CYP3A4—Vinorelbine—ovarian cancer	0.0493	0.162	CbGbCtD
Rivastigmine—CYP3A4—Paclitaxel—ovarian cancer	0.0346	0.114	CbGbCtD
Rivastigmine—CYP2D6—Doxorubicin—ovarian cancer	0.0294	0.0964	CbGbCtD
Rivastigmine—CYP3A4—Docetaxel—ovarian cancer	0.025	0.0822	CbGbCtD
Rivastigmine—CYP3A4—Doxorubicin—ovarian cancer	0.0187	0.0613	CbGbCtD
Rivastigmine—BCHE—diaphragm—ovarian cancer	0.0141	0.486	CbGeAlD
Rivastigmine—Neostigmine—ABCB1—ovarian cancer	0.00177	1	CrCbGaD
Rivastigmine—BCHE—myometrium—ovarian cancer	0.00172	0.0591	CbGeAlD
Rivastigmine—ACHE—testis—ovarian cancer	0.00164	0.0566	CbGeAlD
Rivastigmine—BCHE—uterine cervix—ovarian cancer	0.00134	0.046	CbGeAlD
Rivastigmine—BCHE—endometrium—ovarian cancer	0.00121	0.0416	CbGeAlD
Rivastigmine—ACHE—lymph node—ovarian cancer	0.00119	0.041	CbGeAlD
Rivastigmine—BCHE—uterus—ovarian cancer	0.00111	0.0383	CbGeAlD
Rivastigmine—BCHE—female reproductive system—ovarian cancer	0.001	0.0345	CbGeAlD
Rivastigmine—BCHE—bone marrow—ovarian cancer	0.000945	0.0325	CbGeAlD
Rivastigmine—BCHE—vagina—ovarian cancer	0.000905	0.0312	CbGeAlD
Rivastigmine—BCHE—testis—ovarian cancer	0.000808	0.0278	CbGeAlD
Rivastigmine—CYP3A4—female reproductive system—ovarian cancer	0.000674	0.0232	CbGeAlD
Rivastigmine—CYP2D6—female reproductive system—ovarian cancer	0.000663	0.0228	CbGeAlD
Rivastigmine—CYP2D6—female gonad—ovarian cancer	0.000604	0.0208	CbGeAlD
Rivastigmine—BCHE—lymph node—ovarian cancer	0.000586	0.0202	CbGeAlD
Rivastigmine—CYP2D6—testis—ovarian cancer	0.000535	0.0184	CbGeAlD
Rivastigmine—Sweating—Epirubicin—ovarian cancer	0.000239	0.00036	CcSEcCtD
Rivastigmine—Pollakiuria—Doxorubicin—ovarian cancer	0.000239	0.00036	CcSEcCtD
Rivastigmine—Pain—Paclitaxel—ovarian cancer	0.000238	0.000358	CcSEcCtD
Rivastigmine—Constipation—Paclitaxel—ovarian cancer	0.000238	0.000358	CcSEcCtD
Rivastigmine—Haematuria—Epirubicin—ovarian cancer	0.000238	0.000358	CcSEcCtD
Rivastigmine—Confusional state—Docetaxel—ovarian cancer	0.000238	0.000358	CcSEcCtD
Rivastigmine—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000236	0.000356	CcSEcCtD
Rivastigmine—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000236	0.000355	CcSEcCtD
Rivastigmine—Oedema—Docetaxel—ovarian cancer	0.000236	0.000355	CcSEcCtD
Rivastigmine—Weight increased—Doxorubicin—ovarian cancer	0.000236	0.000354	CcSEcCtD
Rivastigmine—Epistaxis—Epirubicin—ovarian cancer	0.000235	0.000354	CcSEcCtD
Rivastigmine—Infection—Docetaxel—ovarian cancer	0.000234	0.000353	CcSEcCtD
Rivastigmine—Weight decreased—Doxorubicin—ovarian cancer	0.000234	0.000352	CcSEcCtD
Rivastigmine—Sinusitis—Epirubicin—ovarian cancer	0.000234	0.000352	CcSEcCtD
Rivastigmine—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000234	0.000351	CcSEcCtD
Rivastigmine—Pneumonia—Doxorubicin—ovarian cancer	0.000232	0.000349	CcSEcCtD
Rivastigmine—Shock—Docetaxel—ovarian cancer	0.000232	0.000349	CcSEcCtD
Rivastigmine—Nervous system disorder—Docetaxel—ovarian cancer	0.000231	0.000348	CcSEcCtD
Rivastigmine—Thrombocytopenia—Docetaxel—ovarian cancer	0.000231	0.000348	CcSEcCtD
Rivastigmine—Drowsiness—Doxorubicin—ovarian cancer	0.000231	0.000347	CcSEcCtD
Rivastigmine—Infestation—Doxorubicin—ovarian cancer	0.000231	0.000347	CcSEcCtD
Rivastigmine—Infestation NOS—Doxorubicin—ovarian cancer	0.000231	0.000347	CcSEcCtD
Rivastigmine—Tachycardia—Docetaxel—ovarian cancer	0.00023	0.000346	CcSEcCtD
Rivastigmine—Feeling abnormal—Paclitaxel—ovarian cancer	0.000229	0.000345	CcSEcCtD
Rivastigmine—Skin disorder—Docetaxel—ovarian cancer	0.000229	0.000345	CcSEcCtD
Rivastigmine—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000229	0.000344	CcSEcCtD
Rivastigmine—Bradycardia—Epirubicin—ovarian cancer	0.000228	0.000343	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000228	0.000342	CcSEcCtD
Rivastigmine—Renal failure—Doxorubicin—ovarian cancer	0.000227	0.000341	CcSEcCtD
Rivastigmine—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000226	0.00034	CcSEcCtD
Rivastigmine—Haemoglobin—Epirubicin—ovarian cancer	0.000225	0.000339	CcSEcCtD
Rivastigmine—Anorexia—Docetaxel—ovarian cancer	0.000225	0.000338	CcSEcCtD
Rivastigmine—Rhinitis—Epirubicin—ovarian cancer	0.000225	0.000338	CcSEcCtD
Rivastigmine—Urinary tract infection—Doxorubicin—ovarian cancer	0.000224	0.000338	CcSEcCtD
Rivastigmine—Conjunctivitis—Doxorubicin—ovarian cancer	0.000224	0.000338	CcSEcCtD
Rivastigmine—Haemorrhage—Epirubicin—ovarian cancer	0.000224	0.000337	CcSEcCtD
Rivastigmine—Hepatitis—Epirubicin—ovarian cancer	0.000224	0.000337	CcSEcCtD
Rivastigmine—Hypoaesthesia—Epirubicin—ovarian cancer	0.000223	0.000335	CcSEcCtD
Rivastigmine—Pharyngitis—Epirubicin—ovarian cancer	0.000222	0.000334	CcSEcCtD
Rivastigmine—Sweating—Doxorubicin—ovarian cancer	0.000221	0.000333	CcSEcCtD
Rivastigmine—Urinary tract disorder—Epirubicin—ovarian cancer	0.000221	0.000333	CcSEcCtD
Rivastigmine—Urticaria—Paclitaxel—ovarian cancer	0.000221	0.000333	CcSEcCtD
Rivastigmine—Oedema peripheral—Epirubicin—ovarian cancer	0.000221	0.000332	CcSEcCtD
Rivastigmine—Hypotension—Docetaxel—ovarian cancer	0.00022	0.000332	CcSEcCtD
Rivastigmine—Haematuria—Doxorubicin—ovarian cancer	0.00022	0.000331	CcSEcCtD
Rivastigmine—Connective tissue disorder—Epirubicin—ovarian cancer	0.00022	0.000331	CcSEcCtD
Rivastigmine—Body temperature increased—Paclitaxel—ovarian cancer	0.00022	0.000331	CcSEcCtD
Rivastigmine—Abdominal pain—Paclitaxel—ovarian cancer	0.00022	0.000331	CcSEcCtD
Rivastigmine—Urethral disorder—Epirubicin—ovarian cancer	0.00022	0.00033	CcSEcCtD
Rivastigmine—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000218	0.000328	CcSEcCtD
Rivastigmine—Epistaxis—Doxorubicin—ovarian cancer	0.000218	0.000328	CcSEcCtD
Rivastigmine—Sinusitis—Doxorubicin—ovarian cancer	0.000217	0.000326	CcSEcCtD
Rivastigmine—Visual impairment—Epirubicin—ovarian cancer	0.000216	0.000325	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000215	0.000323	CcSEcCtD
Rivastigmine—Insomnia—Docetaxel—ovarian cancer	0.000213	0.000321	CcSEcCtD
Rivastigmine—Paraesthesia—Docetaxel—ovarian cancer	0.000212	0.000319	CcSEcCtD
Rivastigmine—Erythema multiforme—Epirubicin—ovarian cancer	0.000212	0.000319	CcSEcCtD
Rivastigmine—Bradycardia—Doxorubicin—ovarian cancer	0.000211	0.000317	CcSEcCtD
Rivastigmine—Dyspnoea—Docetaxel—ovarian cancer	0.00021	0.000316	CcSEcCtD
Rivastigmine—Somnolence—Docetaxel—ovarian cancer	0.00021	0.000316	CcSEcCtD
Rivastigmine—Eye disorder—Epirubicin—ovarian cancer	0.000209	0.000315	CcSEcCtD
Rivastigmine—Tinnitus—Epirubicin—ovarian cancer	0.000209	0.000314	CcSEcCtD
Rivastigmine—Haemoglobin—Doxorubicin—ovarian cancer	0.000208	0.000313	CcSEcCtD
Rivastigmine—Flushing—Epirubicin—ovarian cancer	0.000208	0.000313	CcSEcCtD
Rivastigmine—Cardiac disorder—Epirubicin—ovarian cancer	0.000208	0.000313	CcSEcCtD
Rivastigmine—Rhinitis—Doxorubicin—ovarian cancer	0.000208	0.000313	CcSEcCtD
Rivastigmine—Dyspepsia—Docetaxel—ovarian cancer	0.000208	0.000312	CcSEcCtD
Rivastigmine—Haemorrhage—Doxorubicin—ovarian cancer	0.000207	0.000312	CcSEcCtD
Rivastigmine—Hepatitis—Doxorubicin—ovarian cancer	0.000207	0.000312	CcSEcCtD
Rivastigmine—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000206	0.00031	CcSEcCtD
Rivastigmine—Pharyngitis—Doxorubicin—ovarian cancer	0.000206	0.000309	CcSEcCtD
Rivastigmine—Decreased appetite—Docetaxel—ovarian cancer	0.000205	0.000309	CcSEcCtD
Rivastigmine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000205	0.000309	CcSEcCtD
Rivastigmine—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000205	0.000308	CcSEcCtD
Rivastigmine—Oedema peripheral—Doxorubicin—ovarian cancer	0.000204	0.000307	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000204	0.000306	CcSEcCtD
Rivastigmine—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000204	0.000306	CcSEcCtD
Rivastigmine—Fatigue—Docetaxel—ovarian cancer	0.000203	0.000306	CcSEcCtD
Rivastigmine—Angiopathy—Epirubicin—ovarian cancer	0.000203	0.000306	CcSEcCtD
Rivastigmine—Urethral disorder—Doxorubicin—ovarian cancer	0.000203	0.000306	CcSEcCtD
Rivastigmine—Mediastinal disorder—Epirubicin—ovarian cancer	0.000202	0.000304	CcSEcCtD
Rivastigmine—Pain—Docetaxel—ovarian cancer	0.000202	0.000304	CcSEcCtD
Rivastigmine—Constipation—Docetaxel—ovarian cancer	0.000202	0.000304	CcSEcCtD
Rivastigmine—Chills—Epirubicin—ovarian cancer	0.000201	0.000302	CcSEcCtD
Rivastigmine—Arrhythmia—Epirubicin—ovarian cancer	0.0002	0.000301	CcSEcCtD
Rivastigmine—Visual impairment—Doxorubicin—ovarian cancer	0.0002	0.0003	CcSEcCtD
Rivastigmine—Asthenia—Paclitaxel—ovarian cancer	0.0002	0.0003	CcSEcCtD
Rivastigmine—Alopecia—Epirubicin—ovarian cancer	0.000198	0.000298	CcSEcCtD
Rivastigmine—Pruritus—Paclitaxel—ovarian cancer	0.000197	0.000296	CcSEcCtD
Rivastigmine—Mental disorder—Epirubicin—ovarian cancer	0.000196	0.000295	CcSEcCtD
Rivastigmine—Erythema multiforme—Doxorubicin—ovarian cancer	0.000196	0.000295	CcSEcCtD
Rivastigmine—Erythema—Epirubicin—ovarian cancer	0.000195	0.000293	CcSEcCtD
Rivastigmine—Malnutrition—Epirubicin—ovarian cancer	0.000195	0.000293	CcSEcCtD
Rivastigmine—Feeling abnormal—Docetaxel—ovarian cancer	0.000194	0.000292	CcSEcCtD
Rivastigmine—Eye disorder—Doxorubicin—ovarian cancer	0.000194	0.000291	CcSEcCtD
Rivastigmine—Tinnitus—Doxorubicin—ovarian cancer	0.000193	0.000291	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000193	0.00029	CcSEcCtD
Rivastigmine—Flushing—Doxorubicin—ovarian cancer	0.000192	0.000289	CcSEcCtD
Rivastigmine—Cardiac disorder—Doxorubicin—ovarian cancer	0.000192	0.000289	CcSEcCtD
Rivastigmine—Flatulence—Epirubicin—ovarian cancer	0.000192	0.000289	CcSEcCtD
Rivastigmine—Tension—Epirubicin—ovarian cancer	0.000191	0.000288	CcSEcCtD
Rivastigmine—Dysgeusia—Epirubicin—ovarian cancer	0.000191	0.000287	CcSEcCtD
Rivastigmine—Diarrhoea—Paclitaxel—ovarian cancer	0.00019	0.000287	CcSEcCtD
Rivastigmine—Nervousness—Epirubicin—ovarian cancer	0.000189	0.000285	CcSEcCtD
Rivastigmine—Back pain—Epirubicin—ovarian cancer	0.000189	0.000284	CcSEcCtD
Rivastigmine—Angiopathy—Doxorubicin—ovarian cancer	0.000188	0.000283	CcSEcCtD
Rivastigmine—Muscle spasms—Epirubicin—ovarian cancer	0.000187	0.000282	CcSEcCtD
Rivastigmine—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000187	0.000281	CcSEcCtD
Rivastigmine—Body temperature increased—Docetaxel—ovarian cancer	0.000186	0.000281	CcSEcCtD
Rivastigmine—Abdominal pain—Docetaxel—ovarian cancer	0.000186	0.000281	CcSEcCtD
Rivastigmine—Chills—Doxorubicin—ovarian cancer	0.000186	0.00028	CcSEcCtD
Rivastigmine—Arrhythmia—Doxorubicin—ovarian cancer	0.000185	0.000279	CcSEcCtD
Rivastigmine—Dizziness—Paclitaxel—ovarian cancer	0.000184	0.000277	CcSEcCtD
Rivastigmine—Vision blurred—Epirubicin—ovarian cancer	0.000184	0.000276	CcSEcCtD
Rivastigmine—Alopecia—Doxorubicin—ovarian cancer	0.000183	0.000276	CcSEcCtD
Rivastigmine—Mental disorder—Doxorubicin—ovarian cancer	0.000182	0.000273	CcSEcCtD
Rivastigmine—Ill-defined disorder—Epirubicin—ovarian cancer	0.000181	0.000272	CcSEcCtD
Rivastigmine—Malnutrition—Doxorubicin—ovarian cancer	0.00018	0.000271	CcSEcCtD
Rivastigmine—Erythema—Doxorubicin—ovarian cancer	0.00018	0.000271	CcSEcCtD
Rivastigmine—Anaemia—Epirubicin—ovarian cancer	0.00018	0.000271	CcSEcCtD
Rivastigmine—Agitation—Epirubicin—ovarian cancer	0.000179	0.00027	CcSEcCtD
Rivastigmine—Flatulence—Doxorubicin—ovarian cancer	0.000178	0.000267	CcSEcCtD
Rivastigmine—Tension—Doxorubicin—ovarian cancer	0.000177	0.000266	CcSEcCtD
Rivastigmine—Vomiting—Paclitaxel—ovarian cancer	0.000177	0.000266	CcSEcCtD
Rivastigmine—Dysgeusia—Doxorubicin—ovarian cancer	0.000177	0.000266	CcSEcCtD
Rivastigmine—Malaise—Epirubicin—ovarian cancer	0.000176	0.000265	CcSEcCtD
Rivastigmine—Rash—Paclitaxel—ovarian cancer	0.000175	0.000264	CcSEcCtD
Rivastigmine—Dermatitis—Paclitaxel—ovarian cancer	0.000175	0.000264	CcSEcCtD
Rivastigmine—Nervousness—Doxorubicin—ovarian cancer	0.000175	0.000264	CcSEcCtD
Rivastigmine—Vertigo—Epirubicin—ovarian cancer	0.000175	0.000264	CcSEcCtD
Rivastigmine—Syncope—Epirubicin—ovarian cancer	0.000175	0.000263	CcSEcCtD
Rivastigmine—Back pain—Doxorubicin—ovarian cancer	0.000174	0.000263	CcSEcCtD
Rivastigmine—Headache—Paclitaxel—ovarian cancer	0.000174	0.000262	CcSEcCtD
Rivastigmine—Hypersensitivity—Docetaxel—ovarian cancer	0.000174	0.000261	CcSEcCtD
Rivastigmine—Muscle spasms—Doxorubicin—ovarian cancer	0.000173	0.000261	CcSEcCtD
Rivastigmine—Palpitations—Epirubicin—ovarian cancer	0.000172	0.000259	CcSEcCtD
Rivastigmine—Loss of consciousness—Epirubicin—ovarian cancer	0.000171	0.000258	CcSEcCtD
Rivastigmine—Cough—Epirubicin—ovarian cancer	0.00017	0.000256	CcSEcCtD
Rivastigmine—Vision blurred—Doxorubicin—ovarian cancer	0.00017	0.000256	CcSEcCtD
Rivastigmine—Asthenia—Docetaxel—ovarian cancer	0.000169	0.000255	CcSEcCtD
Rivastigmine—Convulsion—Epirubicin—ovarian cancer	0.000169	0.000254	CcSEcCtD
Rivastigmine—Hypertension—Epirubicin—ovarian cancer	0.000168	0.000253	CcSEcCtD
Rivastigmine—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000167	0.000252	CcSEcCtD
Rivastigmine—Pruritus—Docetaxel—ovarian cancer	0.000167	0.000251	CcSEcCtD
Rivastigmine—Anaemia—Doxorubicin—ovarian cancer	0.000167	0.000251	CcSEcCtD
Rivastigmine—Myalgia—Epirubicin—ovarian cancer	0.000166	0.00025	CcSEcCtD
Rivastigmine—Arthralgia—Epirubicin—ovarian cancer	0.000166	0.00025	CcSEcCtD
Rivastigmine—Chest pain—Epirubicin—ovarian cancer	0.000166	0.00025	CcSEcCtD
Rivastigmine—Agitation—Doxorubicin—ovarian cancer	0.000166	0.000249	CcSEcCtD
Rivastigmine—Anxiety—Epirubicin—ovarian cancer	0.000165	0.000249	CcSEcCtD
Rivastigmine—Nausea—Paclitaxel—ovarian cancer	0.000165	0.000249	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000165	0.000248	CcSEcCtD
Rivastigmine—Discomfort—Epirubicin—ovarian cancer	0.000164	0.000247	CcSEcCtD
Rivastigmine—Malaise—Doxorubicin—ovarian cancer	0.000163	0.000245	CcSEcCtD
Rivastigmine—Dry mouth—Epirubicin—ovarian cancer	0.000162	0.000244	CcSEcCtD
Rivastigmine—Vertigo—Doxorubicin—ovarian cancer	0.000162	0.000244	CcSEcCtD
Rivastigmine—Syncope—Doxorubicin—ovarian cancer	0.000162	0.000243	CcSEcCtD
Rivastigmine—Diarrhoea—Docetaxel—ovarian cancer	0.000161	0.000243	CcSEcCtD
Rivastigmine—Confusional state—Epirubicin—ovarian cancer	0.00016	0.000241	CcSEcCtD
Rivastigmine—Palpitations—Doxorubicin—ovarian cancer	0.000159	0.00024	CcSEcCtD
Rivastigmine—Oedema—Epirubicin—ovarian cancer	0.000159	0.000239	CcSEcCtD
Rivastigmine—Loss of consciousness—Doxorubicin—ovarian cancer	0.000159	0.000239	CcSEcCtD
Rivastigmine—Infection—Epirubicin—ovarian cancer	0.000158	0.000238	CcSEcCtD
Rivastigmine—Cough—Doxorubicin—ovarian cancer	0.000157	0.000237	CcSEcCtD
Rivastigmine—Shock—Epirubicin—ovarian cancer	0.000157	0.000236	CcSEcCtD
Rivastigmine—Convulsion—Doxorubicin—ovarian cancer	0.000156	0.000235	CcSEcCtD
Rivastigmine—Nervous system disorder—Epirubicin—ovarian cancer	0.000156	0.000235	CcSEcCtD
Rivastigmine—Dizziness—Docetaxel—ovarian cancer	0.000156	0.000235	CcSEcCtD
Rivastigmine—Thrombocytopenia—Epirubicin—ovarian cancer	0.000156	0.000234	CcSEcCtD
Rivastigmine—Hypertension—Doxorubicin—ovarian cancer	0.000156	0.000234	CcSEcCtD
Rivastigmine—Tachycardia—Epirubicin—ovarian cancer	0.000155	0.000234	CcSEcCtD
Rivastigmine—Skin disorder—Epirubicin—ovarian cancer	0.000155	0.000233	CcSEcCtD
Rivastigmine—Hyperhidrosis—Epirubicin—ovarian cancer	0.000154	0.000231	CcSEcCtD
Rivastigmine—Arthralgia—Doxorubicin—ovarian cancer	0.000154	0.000231	CcSEcCtD
Rivastigmine—Chest pain—Doxorubicin—ovarian cancer	0.000154	0.000231	CcSEcCtD
Rivastigmine—Myalgia—Doxorubicin—ovarian cancer	0.000154	0.000231	CcSEcCtD
Rivastigmine—Anxiety—Doxorubicin—ovarian cancer	0.000153	0.00023	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000153	0.000229	CcSEcCtD
Rivastigmine—Discomfort—Doxorubicin—ovarian cancer	0.000152	0.000228	CcSEcCtD
Rivastigmine—Anorexia—Epirubicin—ovarian cancer	0.000152	0.000228	CcSEcCtD
Rivastigmine—Dry mouth—Doxorubicin—ovarian cancer	0.00015	0.000226	CcSEcCtD
Rivastigmine—Vomiting—Docetaxel—ovarian cancer	0.00015	0.000226	CcSEcCtD
Rivastigmine—Rash—Docetaxel—ovarian cancer	0.000149	0.000224	CcSEcCtD
Rivastigmine—Hypotension—Epirubicin—ovarian cancer	0.000149	0.000224	CcSEcCtD
Rivastigmine—Dermatitis—Docetaxel—ovarian cancer	0.000149	0.000224	CcSEcCtD
Rivastigmine—Confusional state—Doxorubicin—ovarian cancer	0.000148	0.000223	CcSEcCtD
Rivastigmine—Headache—Docetaxel—ovarian cancer	0.000148	0.000222	CcSEcCtD
Rivastigmine—Oedema—Doxorubicin—ovarian cancer	0.000147	0.000222	CcSEcCtD
Rivastigmine—Infection—Doxorubicin—ovarian cancer	0.000146	0.00022	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000145	0.000218	CcSEcCtD
Rivastigmine—Shock—Doxorubicin—ovarian cancer	0.000145	0.000218	CcSEcCtD
Rivastigmine—Nervous system disorder—Doxorubicin—ovarian cancer	0.000144	0.000217	CcSEcCtD
Rivastigmine—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000144	0.000217	CcSEcCtD
Rivastigmine—Insomnia—Epirubicin—ovarian cancer	0.000144	0.000217	CcSEcCtD
Rivastigmine—Tachycardia—Doxorubicin—ovarian cancer	0.000144	0.000216	CcSEcCtD
Rivastigmine—Skin disorder—Doxorubicin—ovarian cancer	0.000143	0.000215	CcSEcCtD
Rivastigmine—Paraesthesia—Epirubicin—ovarian cancer	0.000143	0.000215	CcSEcCtD
Rivastigmine—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000142	0.000214	CcSEcCtD
Rivastigmine—Dyspnoea—Epirubicin—ovarian cancer	0.000142	0.000213	CcSEcCtD
Rivastigmine—Somnolence—Epirubicin—ovarian cancer	0.000141	0.000213	CcSEcCtD
Rivastigmine—Anorexia—Doxorubicin—ovarian cancer	0.00014	0.000211	CcSEcCtD
Rivastigmine—Nausea—Docetaxel—ovarian cancer	0.00014	0.000211	CcSEcCtD
Rivastigmine—Dyspepsia—Epirubicin—ovarian cancer	0.00014	0.000211	CcSEcCtD
Rivastigmine—Decreased appetite—Epirubicin—ovarian cancer	0.000138	0.000208	CcSEcCtD
Rivastigmine—Hypotension—Doxorubicin—ovarian cancer	0.000138	0.000207	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000137	0.000207	CcSEcCtD
Rivastigmine—Fatigue—Epirubicin—ovarian cancer	0.000137	0.000206	CcSEcCtD
Rivastigmine—Constipation—Epirubicin—ovarian cancer	0.000136	0.000205	CcSEcCtD
Rivastigmine—Pain—Epirubicin—ovarian cancer	0.000136	0.000205	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000134	0.000202	CcSEcCtD
Rivastigmine—Insomnia—Doxorubicin—ovarian cancer	0.000133	0.0002	CcSEcCtD
Rivastigmine—Paraesthesia—Doxorubicin—ovarian cancer	0.000132	0.000199	CcSEcCtD
Rivastigmine—Dyspnoea—Doxorubicin—ovarian cancer	0.000131	0.000197	CcSEcCtD
Rivastigmine—Feeling abnormal—Epirubicin—ovarian cancer	0.000131	0.000197	CcSEcCtD
Rivastigmine—Somnolence—Doxorubicin—ovarian cancer	0.000131	0.000197	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Epirubicin—ovarian cancer	0.00013	0.000196	CcSEcCtD
Rivastigmine—Dyspepsia—Doxorubicin—ovarian cancer	0.00013	0.000195	CcSEcCtD
Rivastigmine—Decreased appetite—Doxorubicin—ovarian cancer	0.000128	0.000193	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000127	0.000191	CcSEcCtD
Rivastigmine—Fatigue—Doxorubicin—ovarian cancer	0.000127	0.000191	CcSEcCtD
Rivastigmine—Urticaria—Epirubicin—ovarian cancer	0.000126	0.00019	CcSEcCtD
Rivastigmine—Constipation—Doxorubicin—ovarian cancer	0.000126	0.000189	CcSEcCtD
Rivastigmine—Pain—Doxorubicin—ovarian cancer	0.000126	0.000189	CcSEcCtD
Rivastigmine—Body temperature increased—Epirubicin—ovarian cancer	0.000126	0.000189	CcSEcCtD
Rivastigmine—Abdominal pain—Epirubicin—ovarian cancer	0.000126	0.000189	CcSEcCtD
Rivastigmine—Feeling abnormal—Doxorubicin—ovarian cancer	0.000121	0.000183	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.00012	0.000181	CcSEcCtD
Rivastigmine—Hypersensitivity—Epirubicin—ovarian cancer	0.000117	0.000176	CcSEcCtD
Rivastigmine—Urticaria—Doxorubicin—ovarian cancer	0.000117	0.000176	CcSEcCtD
Rivastigmine—Body temperature increased—Doxorubicin—ovarian cancer	0.000116	0.000175	CcSEcCtD
Rivastigmine—Abdominal pain—Doxorubicin—ovarian cancer	0.000116	0.000175	CcSEcCtD
Rivastigmine—Asthenia—Epirubicin—ovarian cancer	0.000114	0.000172	CcSEcCtD
Rivastigmine—Pruritus—Epirubicin—ovarian cancer	0.000113	0.000169	CcSEcCtD
Rivastigmine—Diarrhoea—Epirubicin—ovarian cancer	0.000109	0.000164	CcSEcCtD
Rivastigmine—Hypersensitivity—Doxorubicin—ovarian cancer	0.000108	0.000163	CcSEcCtD
Rivastigmine—Asthenia—Doxorubicin—ovarian cancer	0.000106	0.000159	CcSEcCtD
Rivastigmine—Dizziness—Epirubicin—ovarian cancer	0.000105	0.000158	CcSEcCtD
Rivastigmine—Pruritus—Doxorubicin—ovarian cancer	0.000104	0.000157	CcSEcCtD
Rivastigmine—Vomiting—Epirubicin—ovarian cancer	0.000101	0.000152	CcSEcCtD
Rivastigmine—Diarrhoea—Doxorubicin—ovarian cancer	0.000101	0.000152	CcSEcCtD
Rivastigmine—Rash—Epirubicin—ovarian cancer	0.0001	0.000151	CcSEcCtD
Rivastigmine—Dermatitis—Epirubicin—ovarian cancer	0.0001	0.000151	CcSEcCtD
Rivastigmine—Headache—Epirubicin—ovarian cancer	9.97e-05	0.00015	CcSEcCtD
Rivastigmine—Dizziness—Doxorubicin—ovarian cancer	9.74e-05	0.000146	CcSEcCtD
Rivastigmine—Nausea—Epirubicin—ovarian cancer	9.45e-05	0.000142	CcSEcCtD
Rivastigmine—Vomiting—Doxorubicin—ovarian cancer	9.36e-05	0.000141	CcSEcCtD
Rivastigmine—Rash—Doxorubicin—ovarian cancer	9.28e-05	0.00014	CcSEcCtD
Rivastigmine—Dermatitis—Doxorubicin—ovarian cancer	9.27e-05	0.00014	CcSEcCtD
Rivastigmine—Headache—Doxorubicin—ovarian cancer	9.22e-05	0.000139	CcSEcCtD
Rivastigmine—Nausea—Doxorubicin—ovarian cancer	8.74e-05	0.000132	CcSEcCtD
